A review on the potential of repurposing of metformin for colon cancer and breast cancer

A review on the potential of repurposing of metformin for colon cancer and breast cancer

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.

Opis bibliograficzny
1. autor:	Oishy, Jannatun Noor
Kolejni autorzy:	Chowdhury, Namara Mariam
Format:	Praca dyplomowa
Język:	English
Wydane:	BRAC University 2024
Hasła przedmiotowe:	Metformin Drug repurposing Cancer Clinical trials Dose Breast > Cancer > Pathophysiology Drug development Metformin > History
Dostęp online:	http://hdl.handle.net/10361/23296

Podobne zapisy

Drug repurposing: potential of Antimicrobial Drugs in Breast Cancer Treatment
od: Chakraborty, Anuradha
Wydane: (2024)

A review on potential anticancer properties of antidiabetic drugs: metformin and sulfonylureas
od: Hossain, Tamara
Wydane: (2024)

A comprehensive review on drug repurposing in cancer treatment
od: Sarkar, Onusree
Wydane: (2024)

A review of Breast Cancer risk factor assessment on women in developing countries, cancer drug resistance, and Breast Cancer treatment in Bangladesh
od: Raihan, Dilraj
Wydane: (2024)

A review on drug repurposing for diabetes epidemic
od: Lamia, Sadia Raisa
Wydane: (2022)

Breast cancer awareness seminars
od: Anwer Khan Modern Medical College
Wydane: (2016)

Breast cancer therapy through Liposomal drug delivery system
od: Ome, Nusrat Jahan
Wydane: (2024)

Targeting DHFR in breast cancer: exploring expression patterns and identifying potential inhibitors through docking studies
od: Araf, Faiaz Fahim
Wydane: (2024)

Pooled analysis of progression-free survival and overall survival in phase II clinical trials of breast cancer
od: Shobnam, Sohana
Wydane: (2024)

Genetic innovations for breast cancer treatment : a review of gene therapy strategies and future implications
od: Hasan, Sakib
Wydane: (2024)

Recent advancement on breast cancer detection and treatment
od: Rahman, Sanjida
Wydane: (2023)

A review on triple-negative breast cancer and its potential treatment
od: Niasa, Jannatul Ferdous
Wydane: (2023)

Targeted therapeutic options in the treatment of Breast Cancer
od: Alam, Kazi Tasnuva
Wydane: (2022)

Natural products and their combinatory effects in breast cancer treatment
od: Siddique, Md. Ayman
Wydane: (2021)

The impact of breast cancer on women’s lives in Bangladesh
od: Mobashera, Tayeeba Tum
Wydane: (2024)

Drug repurposing: search for targeted drug candidates in the treatment of HER2 positive breast cancer
od: Yeasmin, Jahida
Wydane: (2024)

Machine learning as an indicator for breast cancer prediction
od: Shadman, Tahsin Mohammed, i wsp.
Wydane: (2019)

In vitro study on interaction of ketotifen fumarate with metformin hydrochloride
od: Sayeed, Mohammed Aktar, i wsp.
Wydane: (2016)

Comparison of conventional doxorubicin with liposome encapsulated doxorubicin as a treatment of breast cancer-a review
od: Akter, Honufa
Wydane: (2024)

RIPK pathway, as a potential target, for cancer treatment - a review
od: Jahan, Nusrat
Wydane: (2024)

Use of combination of satins as antagonists of SPARC in stomach cancer: an in silico study
od: Rashed, Sadman Sakib Bin
Wydane: (2019)

Effect of performance status on efficacy endpoints in phase II trials of non-small cell lung cancer
od: Paul, Pulock
Wydane: (2024)

Drug Repurposing : search for a drug having effective anticancer activity
od: Khan, Md. Arafat
Wydane: (2018)

Role of statins as antagonists of SPARC in gastric cancer
od: Shahmat, Rad
Wydane: (2019)

Early detection of breast cancer using machine learning
od: Fuad, Wasi Mohammad
Wydane: (2019)

Pathway analysis of Disease-Gene associated network in the human breast cancer
od: Lamia
Wydane: (2020)

Breast cancer in low-resource settings: Prioritizing the awareness and access programmes to overcome sociocultural and economic barriers for early detection and improved outcomes
od: Iqbal, Mohammad Shamim, i wsp.
Wydane: (2017)

Impact of treatment size and therapy type in phase II clinical trials of non-small cell lung cancer
od: Rahman, Tasnim
Wydane: (2024)

Risk of cancer associated with antihypertensive drugs
od: Iqbal, Adnan
Wydane: (2024)

Breast cancer in South Asia: a Bangladeshi perspective
od: Hossain, Mohammad Sorowar, i wsp.
Wydane: (2017)

Efficacy analysis and prediction in phase II clinical trials of non-small cell Lung Cancer
od: Hoque, Ismoth Ara
Wydane: (2024)

A review on recent advances in drugs for lung cancer treatment
od: Noor, Fouzia
Wydane: (2024)

Antihypertensive drugs and risk of cancer: A pharmacovigilance study
od: Rahman, Ahadina
Wydane: (2018)

Breast cancer prediction using different machine learning models
od: Khandker Al- Muhaimin, i wsp.
Wydane: (2020)

Identification of the multi-drug resistant genes in the bacteria isolated from the saliva of smoker oral cancer patients and comparative analysis with smoker normal individuals
od: Hasan, Samir, i wsp.
Wydane: (2024)

In silico analysis revealed hsa-miR-19a-3p and hsa-miR-19b-3p as two potential inhibitors of EGF mRNA in Breast Cancer
od: Nuha, Nabiha Tahsin
Wydane: (2024)

A review on nanoparticles based drug delivery in cancer treatment: advantages & challenges
od: Nahar, Kamrun
Wydane: (2023)

Pooled analysis of response rate and overall survival of Tyrosine Kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
od: Karim, Samia Binte
Wydane: (2024)

Therapeutic prospective of targeting calcium homeostasis in cancer – a review
od: Kamal, Tasnova
Wydane: (2019)

Oncogenes: new targets in cancer treatment
od: Chowdhury, Waseka Shams
Wydane: (2020)